EUVIMEDEUVIMED entdecken
Crossref

Breast Cancer Management with Melanie E Royce: BOLERO-4 Phase II Trial of First-Line Everolimus Plus Letrozole in ER + , HER2 - Advanced Breast Cancer

Melanie E Royce

Breast Cancer Management · 2016

DOI: 10.2217/bmt-2017-0001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Management, 2016. Verfasst von Melanie E Royce. Gefördert von: National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Institutes of Health

Zitieren

APA

Royce, M. E. (2016). Breast Cancer Management with Melanie E Royce: BOLERO-4 Phase II Trial of First-Line Everolimus Plus Letrozole in ER + , HER2 - Advanced Breast Cancer. Breast Cancer Management. https://doi.org/10.2217/bmt-2017-0001

Vancouver

Royce ME. Breast Cancer Management with Melanie E Royce: BOLERO-4 Phase II Trial of First-Line Everolimus Plus Letrozole in ER + , HER2 - Advanced Breast Cancer. Breast Cancer Management. 2016. doi:10.2217/bmt-2017-0001

BibTeX
@article{Royce2016,
  author = {Royce, Melanie E},
  title = {Breast Cancer Management with Melanie E Royce: BOLERO-4 Phase II Trial of First-Line Everolimus Plus Letrozole in ER + , HER2 - Advanced Breast Cancer},
  journal = {Breast Cancer Management},
  year = {2016},
  doi = {10.2217/bmt-2017-0001}
}
Kostenlos starten →